Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Autoimmune Disorders

Free Subscription 30.01.2023 1 BMC Neurol 1 J Clin Endocrinol Metab 1 J Immunol 1 J Neuroimmunol 6 Kidney Int 1 Lancet 4 Mult Scler 2 Neurology 4 PLoS One 1 Proc Natl Acad Sci U S A 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. HOMAYUNHOSSEINI AZ
   An intervention design for promoting quality of life among patients with multiple sclerosis: a protocol with a planning approach for a mixed methods study.
   BMC Neurol. 2023;23:42.
   PubMed         Abstract available
   
   

   
   J Clin Endocrinol Metab

2. BISCARINI F, Masetti G, Muller I, Verhasselt HL, et al
   Gut microbiome associated with Graves' disease and Graves' orbitopathy: the INDIGO* multi-centre European study.
   J Clin Endocrinol Metab. 2023 Jan 23:dgad030. doi: 10.1210.
   PubMed         Abstract available
   
   

   
   J Immunol

3. KIM D, Rai NK, Burrows A, Kim S, et al
   IFN-Induced Protein with Tetratricopeptide Repeats 2 Limits Autoimmune Inflammation by Regulating Myeloid Cell Activation and Metabolic Activity.
   J Immunol. 2023 Jan 25:ji2200746. doi: 10.4049/jimmunol.2200746.
   PubMed         Abstract available
   
   

   
   J Neuroimmunol

4. LI K, Hou L, Tan Y, Huang Y, et al
   Iron metabolism in non-anemic myasthenia gravis patients: A cohort study.
   J Neuroimmunol. 2023;375:578015.
   PubMed         Abstract available
   
   

   
   Kidney Int

5. KAUR P, Prabhahar A, Kumar A, Pal D, et al
   Complementary medicine and phospholipase A2 receptor (PLA2R)-related membranous nephropathy-fortuitous or causal?
   Kidney Int. 2023;103:425-427.
   PubMed        
   
   
6. CAZA TN, Larsen CP
   False-positive anti-PLA2R ELISA testing in patients with diabetes mellitus.
   Kidney Int. 2023;103:425.
   PubMed        
   
   
7. COPPO R
   A disease-modifying approach to the treatment of IgA nephropathy targeting mucosal IgA synthesis and beyond.
   Kidney Int. 2023;103:258-261.
   PubMed         Abstract available
   
   
8. BIHL F, Lambeau G
   Toward a bona fide animal model of PLA2R1-associated membranous nephropathy: one step forward.
   Kidney Int. 2023;103:251-253.
   PubMed         Abstract available
   
   
9. SI M, Li L, Fang M, Ye Z, et al
   Anomalous kinetics of galactose-deficient IgA incurring nephropathy revealed by cross-scale optical imaging.
   Kidney Int. 2023;103:320-330.
   PubMed         Abstract available
   
   
10. BARRATT J, Lafayette R, Kristensen J, Stone A, et al
    Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
    Kidney Int. 2023;103:391-402.
    PubMed         Abstract available
    
    

    
    Lancet

11. GUGER M, Ransmayr G, Sonnberger M, Hametner S, et al
    Tumefactive multiple sclerosis presents with painless progressive hemiparesis and aphasia.
    Lancet. 2023;401:226.
    PubMed        
    
    

    
    Mult Scler

12. ABBADESSA G, Miele G, Maida E, Vanore E, et al
    Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis.
    Mult Scler. 2023 Jan 22:13524585221147635. doi: 10.1177/13524585221147635.
    PubMed         Abstract available
    
    
13. SADOVNICK D, Criscuoli M, Yee I, Carruthers R, et al
    The Canadian Multiple Sclerosis Pregnancy Study: First-trimester miscarriages in women with multiple sclerosis.
    Mult Scler. 2023 Jan 22:13524585221146270. doi: 10.1177/13524585221146270.
    PubMed         Abstract available
    
    
14. HU C, Dewey BE, Mowry EM, Fitzgerald KC, et al
    Deep gray matter substructure volumes and depressive symptoms in a large multiple sclerosis cohort.
    Mult Scler. 2023 Jan 24:13524585221148144. doi: 10.1177/13524585221148144.
    PubMed         Abstract available
    
    
15. CHIA NH, Redenbaugh V, Chen JJ, Pittock SJ, et al
    Corpus callosum involvement in MOG antibody-associated disease in comparison to AQP4-IgG-seropositive neuromyelitis optica spectrum disorder and multiple sclerosis.
    Mult Scler. 2023 Jan 24:13524585221150743. doi: 10.1177/13524585221150743.
    PubMed         Abstract available
    
    

    
    Neurology

16. 
    Pathologic Features of Anti-Mi-2 Dermatomyositis.
    Neurology. 2023 Jan 24:10.1212/WNL.0000000000201611.
    PubMed        
    
    
17. CACCIAGUERRA L, Morris P, Tobin WO, Chen JJ, et al
    Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.
    Neurology. 2023 Jan 23:10.1212/WNL.0000000000206820.
    PubMed         Abstract available
    
    

    
    PLoS One

18. PRUMMER JK, Stein VM, Marti E, Lutterotti A, et al
    Assessment of oligoclonal bands in cerebrospinal fluid and serum of dogs with meningoencephalitis of unknown origin.
    PLoS One. 2023;18:e0280864.
    PubMed         Abstract available
    
    
19. DIAS HF, Mochizuki Y, Kuhtreiber WM, Takahashi H, et al
    Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: Results of two observational studies.
    PLoS One. 2023;18:e0276423.
    PubMed         Abstract available
    
    
20. DE SONNAVILLE WFC, Steenks MH, Zuithoff NPA, Wulffraat NM, et al
    Reliability and measurement error of anterior maximum voluntary bite force in children with juvenile idiopathic arthritis and healthy children.
    PLoS One. 2023;18:e0280763.
    PubMed         Abstract available
    
    
21. KANSUTTIVIWAT C, Niprapan P, Tantiworawit A, Norasetthada L, et al
    Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients.
    PLoS One. 2023;18:e0279450.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

22. SHINODA K, Li R, Rezk A, Mexhitaj I, et al
    Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.
    Proc Natl Acad Sci U S A. 2023;120:e2207291120.
    PubMed         Abstract available
    
    

    
    Thyroid

23. YOSHIHARA A, Noh JY, Inoue K, Watanabe N, et al
    Incidence of and Risk Factors for Neonatal Hypothyroidism among Women with Graves' Disease Treated with Antithyroid Drugs until Delivery.
    Thyroid. 2023 Jan 21. doi: 10.1089/thy.2022.0514.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: